Arthritis Rheumatol:美国人群中抗核抗体的患病率升高

2020-04-08 xiangting MedSci原创

近年来,美国ANA的患病率明显升高。

越来越多的证据表明自身免疫和某些自身免疫性疾病的发病率升高,但是由于缺乏系统性数据以及不断发展的方法和定义,研究结果受到了限制。这里调查了美国最近25年间抗核抗体(ANA)(一种最常见的自身免疫生物标志物)的患病率是否发生了变化。

对14211名≥12岁参与者的HEp-2细胞使用标准间接免疫荧光测定血清ANA,这些参与者来自美国国家健康和营养调查,以下三个时间段各占三分之一:1988-1991年、1999-2004年和2011-2012年。使用针对性别、年龄、种族/民族和调查设计变量进行了调整的logistic回归来估算不同时期ANA患病率的变化。

1988-1991年,ANA的患病率为11.0%(CI=9.7-12.6%),1999-2004年为11.5%(CI=10.3-12.8%),2011-2012年为15.9%(CI=14.3-17.6%)(P趋势<0.0001),分别对应于2200、2700和4100万受影响的个体。在青少年中(12-19岁),ANA患病率急剧上升,相对于第1时间段,第2和第3时间段的比值比分别为2.02(CI=1.16-3.53)和2.88(CI=1.64-5.04)(P趋势<0.0001)。男女(尤其是男性)、老年人(年龄≥50岁)和非西班牙裔白人的ANA患病率升高。共同存在的肥胖/超重、吸烟或饮酒趋势不能解释这些升高。

近年来,美国ANA的患病率明显升高。确定这些升高背后因素的研究可以阐明自身免疫的原因,并有助于制定预防措施。

原始出处:

Gregg E. Dinse. Increasing Prevalence of Antinuclear Antibodies in the United States. Arthritis Rheumatol. 07 April 2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
    2020-04-10 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1972714, encodeId=b51919e27140e, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Thu Jul 02 07:33:06 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910821, encodeId=9e88191082138, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Fri Jun 12 05:33:06 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807340, encodeId=f75c180e340a7, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Jul 04 05:33:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250680, encodeId=0e9d125068078, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357472, encodeId=eb81135e4723d, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585641, encodeId=b826158564169, content=<a href='/topic/show?id=57b35536958' target=_blank style='color:#2F92EE;'>#抗核抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55369, encryptionId=57b35536958, topicName=抗核抗体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43717252607, createdName=mhzhuang@stu.e, createdTime=Fri Apr 10 04:33:06 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

相关资讯

IBD: 大剂量流感疫苗对炎性肠病患者接受抗TNF单一疗法后的免疫原性的影响

背景:抗肿瘤坏死因子α(TNF-α)药物引起的炎症性肠病(IBD)的患者对流感疫苗的免疫反应可能较低。因此,本项研究旨在评估高剂量(HD)与标准剂量(SD)流感疫苗在抗TNF单

Nat Commun:肠道菌群开挂了!自身免疫疾病患病风险不同,肠道菌群就不同

瑞典林雪平大学和美国佛罗里达大学的一项最新研究指出,具有高发性1型糖尿病遗传风险的儿童与低风险儿童相比,其肠道微生物组不同。

Diabetologia:胰岛素原肽可促进自身免疫性糖尿病?

最近对儿童的自然史研究表明,特定的HLA基因型与免疫反应的第一个抗原靶点之间存在联系。然而目前,关于特异性HLA分子对1型糖尿病等自身免疫性疾病病理影响的分子基础尚不清楚。本研究以一种常见的糖尿病相关HLA单倍型为背景,通过探讨胰岛抗原的致糖尿病性来研究这种体内联系。

Neurology:LGI-1自身免疫性脑炎患者3个不同阶段的18F-FDG-PET/SPM分析

50岁女性,睡眠时出现面臂肌张力障碍样发作约50天。

Neurology病例:自身免疫性胶质纤维酸性蛋白脑膜脑脊髓炎

73岁骨髓增生异常综合征女性,表现为认知和运动能力下降2月,伴有头痛和体重下降。查体提示患者思睡,对称齿轮样肌强直,运动迟缓,上臂肌阵挛和反射亢进。

Immunity:高糖确实促炎!华人科学家首次发现,高葡萄糖摄入促进自身免疫的机制,看来吃糖还是得适量

如今,高水平葡萄糖在自身免疫性疾病中的凶犯身份也被揭发了。破解这起谜案的科学家是来自美国国立卫生研究院的Wanjun Chen博士团队,论文发表在《细胞》子刊《免疫》杂志上。